Singh, P.

Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy

New England Journal of Medicine | February 18, 2026 | Volume: 394 | Issue: 13 | Pages: 1334-1336

10.1056/nejme2515777 | PMID 41707168